Searchable abstracts of presentations at key conferences in endocrinology

ea0016p506 | Obesity | ECE2008

Cholinergic regulation of meal induced ghrelin and PYY release is impaired in obesity

Maier Christina , Riedl Michaela , Vila Greisa , Wolzt Michael , Clodi Martin , Ludvik Bernhard , Luger Anton

Ghrelin and PYY are gastrointestinal peptides involved in appetite regulation. The cholinergic part of the vagal nerve participate in the regulation of glucose and insulin levels. We aimed to examine the effects of the cholinergic antagonist atropine on ghrelin, PYY, glucose and insulin under basal conditions and after meal ingestion in lean and obese subjects. Eight lean and eight obese subjects received in a randomized, double-blind, placebo controlled crossover study design...

ea0014p243 | (1) | ECE2007

Fasting and postprandial plasma obestatin levels are reduced in obesity

Maier Christina , Haider Dominik , Vila Greisa , Riedl Michaela , Luger Anton , Wolzt Michael

Obestatin has recently been identified as a peptide derived from pre-proghrelin that opposes ghrelin effects on appetite and body weight in rodents. We studied the effect of food intake on both these hormones in obese and lean subjects and recorded in parallel the subjective sensations of satiety and hunger. Eight obese (two males and six females, BMI=31–52 kg/m2) and eight age- and sex-matched lean subjects (BMI=19–23 kg/m2) were randomized to ...

ea0099oc13.5 | Oral Communications 13: Late Breaking | ECE2024

Use of thiazide diuretics in hypoparathyroidism: indication and effects

Schernthaner-Reiter Marie Helene , Looser Claudius , Nagel Anna , Kautzky-Willer Alexandra , Luger Anton , Vila Greisa

Introduction: Hypoparathyroidism can occur post-surgically after thyroid or parathyroid surgery or in autoimmune or genetic diseases. Over several decades, the management of hypoparathyroidism included only supplementation with calcium, vitamin D3 (cholecaliferol), as well as active 1,25-dihydroxyvitamin D (calcitriol). In cases with severe hypoparathyroidism, this treatment can be limited by hypercalciuria, and these patients often need substitution with recombinant parathyro...

ea0081p404 | Pituitary and Neuroendocrinology | ECE2022

Change in androgens and adrenal hormones during long-term osilodrostat treatment in patients with Cushing’s disease: Results from the Phase III, prospective LINC 3 study

Pivonello Rosario , M.K. Biller Beverly , Akira Shimatsu , Newell-Price John , Tabarin Antoine , Vila Greisa , Piacentini Andrea , Pedroncelli Alberto , Fleseriu Maria

Introduction: Osilodrostat decreases cortisol production by inhibiting 11β-hydroxylase, increasing adrenal hormones above the blockade. Here, we describe these effects of osilodrostat and associated adverse events (AEs). The efficacy and safety of osilodrostat in patients with Cushing’s disease (CD) were confirmed in the published Phase III, prospective LINC 3 study (NCT02180217).Methods: 137 patients with CD (mUFC >1.5x upper limit of norm...

ea0049ep1010 | Pituitary - Clinical | ECE2017

Hypertension, acromegaly and pegvisomant treatment: Experience from ACROSTUDY

Vila Greisa , Jan vanderLely Arrt , Neggers Sebastian , Luger Anton , Webb Susan , Biller Beverly , Jonsson Peter , Hey-Hadavi Judith

Introduction: Hypertension (HTN) is a major cardiovascular (CV) risk factor and independent predictor of the increased mortality in patients with acromegaly. Surgical cure of acromegaly is associated with improvement in blood pressure (BP) levels, however little is known on the effect of pegvisomant (PEGV) treatment on HTN.Methods/design: ACROSTUDY is an open-label, international, prospective, non-interventional study monitoring the long-term safety of P...

ea0041ep780 | Obesity | ECE2016

Glucose and insulin up-regulate the cardiovascular biomarker GDF15 in vivo and in vitro: effect of meal content and obesity

Schernthaner-Reiter Marie Helene , Kasses Dominik , Tugendsam Christina , Riedl Michaela , Peric Slobodan , Clodi Martin , Luger Anton , Vila Greisa

Introduction: Growth differentiation factor 15 (GDF15) has recently been characterized as a cardiovascular risk factor. GDF15 correlates with insulin resistance and obesity in cross-sectional studies and exerts anorexigenic effects in interventional rodent studies. GDF15 has been proposed as a possible therapeutic target in the treatment of obesity, however its meal- and nutrient-dependent regulation in humans has not been investigated previously.Methods...

ea0070ep341 | Pituitary and Neuroendocrinology | ECE2020

Long-term-follow-up of patients with gastric bypass surgery secondary to craniopharyngioma associated hypothalamic obesity

Beiglböck Hannes , Fellinger Paul , Ranzenberger-Haider Tamara , Vila Greisa , Luger Anton , Kautzky-Willer Alexandra , Krebs Michael , Wolf Peter

Background: Patients being cured of craniopharyngioma (CP) often suffer from severe hypothalamic obesity due to tumor localization or therapeutic interventions, which has a major impact on increased mortality and reduced quality of life. Gastric bypass surgery (GBS) was suggested to be an effective therapeutic option for weight reduction in those patients. However, long-term changes in body weight and postsurgical complications are unknown.Methods: 5 pat...

ea0022oc3.1 | Pituitary | ECE2010

Sgk1 effects on POMC transcription and ACTH release are opposite to those of glucocorticoids

Reiter Marie Helene , Vila Greisa , Baumgartner-Parzer Sabina M , Knosp Engelbert , Wagner Ludwig , Stalla Gunter K , Luger Anton

Glucocorticoid feed-back in pituitary corticotrophs represses POMC transcription and ACTH release. Serum and glucocorticoid-induced kinase 1 (Sgk1) has been identified as an immediate early target of glucocorticoids in many tissues, however its expression and function in corticotrophs are unknown.We show here that Sgk1 is present in the human pituitary gland at both mRNA and protein levels. Double-immunohistochemistry revealed that Sgk1 is expressed in d...

ea0022p714 | Obesity | ECE2010

Effects of breastfeeding on maternal appetite-regulating hormones

Vila Greisa , Hopfgartner Judith , Grimm Gabriele , Riedl Michaela , Baumgartner-Parzer Sabina , Kautzky-Willer Alexandra , Clodi Martin , Luger Anton

Gestational weight gain has been linked to obesity in women of childbearing age. Mothers who breastfeed present less postpartum weight retention. The underlying pathophysiological mechanisms are unknown. This study aimed at investigating the impact of breastfeeding on maternal appetite-regulating hormones.The clinical trial recruited 29 women divided in three age- and BMI-matched groups. The first group included 10 fully breastfeeding mothers of 3 to 6 m...

ea0016oc1.9 | Neuroendocrinology and pituitary | ECE2008

Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men

Vila Greisa , Clodi Martin , Geyeregger Rene , Riedl Michaela , Stulnig Thomas M , Struck Joachim , Luger Thomas A , Luger Anton

Oxytocin is a hormone and neurotransmitter with antiinflammatory and neuroimmune-modulatory properties. Physiological states of elevated plasma oxytocin levels are associated with reduced hypothalamic–pituitaty–adrenal response to different stressors. We examined the effect of exogenous oxytocin administration on bacterial endotoxin induced innate immune responses in humans. Ten healthy men received in a randomized, placebo-controlled, cross-over design (1) placebo, ...